Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    12112074 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: ACTOS (Pioglitazone)

Study has passed its completion date and status has not been verified in more than two years.